April 20, 2014 2:51 PM ET

Biotechnology

Company Overview of Riverside Therapeutics Inc.

Company Overview

Riverside Therapeutics, Inc., a development stage biopharmaceutical company, does not have significant operations. It seeks to acquire the rights to develop and commercialize therapeutic drug candidates designed to treat unmet medical needs in the area of oncology. The company may also pursue opportunities that treat, prevent, or detect other human illnesses, such as cardiology or immunology. Riverside Therapeutics was incorporated in May 2004 and is based in New York City.

787 7th Avenue 48th Floor

New York, NY 10019

United States

Founded in 2004

Phone:

212-554-4300

Key Executives for Riverside Therapeutics Inc.

Principal Executive Officer
Age: 50
Principal Financial Officer
Age: 44
Secretary and Director
Age: 41
Compensation as of Fiscal Year 2013.

Similar Private Companies By Industry

Company Name Region
IDM, Inc. United States
XL Techgroup, Inc. United States
Reata Pharmaceuticals, Inc. United States
Renaissance Biomedical Technologies, Inc. United States
Aspira Biosystems, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Riverside Therapeutics Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.